Birchview Capital as of Dec. 31, 2018
Portfolio Holdings for Birchview Capital
Birchview Capital holds 52 positions in its portfolio as reported in the December 2018 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Celgene Corporation | 42.4 | $45M | 699k | 64.09 | |
Accelr8 Technology | 23.8 | $25M | 2.2M | 11.50 | |
Neurocrine Biosciences (NBIX) | 3.7 | $3.9M | 55k | 71.42 | |
Clementia | 2.5 | $2.6M | 222k | 11.76 | |
Array BioPharma | 2.3 | $2.4M | 168k | 14.25 | |
Quidel Corporation | 2.2 | $2.3M | 47k | 48.82 | |
Eqt Midstream Partners | 2.0 | $2.2M | 50k | 43.26 | |
Vanda Pharmaceuticals (VNDA) | 2.0 | $2.1M | 80k | 26.12 | |
Atara Biotherapeutics (ATRA) | 1.1 | $1.2M | 34k | 34.74 | |
Soleno Therapeutics | 1.1 | $1.1M | 657k | 1.71 | |
Imprimis Pharmaceuticals | 1.0 | $1.0M | 180k | 5.69 | |
Oxford Immunotec Global | 1.0 | $1.0M | 80k | 12.78 | |
Albireo Pharma | 0.9 | $932k | 38k | 24.53 | |
Masimo Corporation (MASI) | 0.8 | $859k | 8.0k | 107.38 | |
Arena Pharmaceuticals | 0.8 | $857k | 22k | 38.95 | |
Wright Medical | 0.8 | $817k | 30k | 27.23 | |
Acceleron Pharma | 0.8 | $813k | 19k | 43.54 | |
Biogen Idec (BIIB) | 0.7 | $752k | 2.5k | 300.80 | |
Corcept Therapeutics Incorporated (CORT) | 0.6 | $668k | 50k | 13.36 | |
Karyopharm Therapeutics (KPTI) | 0.6 | $656k | 70k | 9.37 | |
Vermillion | 0.6 | $634k | 2.1M | 0.30 | |
Veracyte (VCYT) | 0.6 | $613k | 49k | 12.57 | |
Inflarx Nv (IFRX) | 0.6 | $582k | 16k | 36.38 | |
Amarin Corporation (AMRN) | 0.5 | $544k | 40k | 13.60 | |
Sientra | 0.5 | $508k | 40k | 12.70 | |
Pioneer Natural Resources (PXD) | 0.5 | $500k | 3.8k | 131.58 | |
Dicerna Pharmaceuticals | 0.5 | $481k | 45k | 10.69 | |
Xencor (XNCR) | 0.4 | $445k | 12k | 36.18 | |
Intercept Pharmaceuticals In | 0.4 | $433k | 4.3k | 100.70 | |
Arvinas Ord (ARVN) | 0.4 | $386k | 30k | 12.87 | |
Contrafect | 0.3 | $368k | 240k | 1.53 | |
Amicus Therapeutics (FOLD) | 0.3 | $364k | 38k | 9.58 | |
Continental Resources | 0.3 | $322k | 8.0k | 40.25 | |
Encana Corp | 0.3 | $320k | 55k | 5.79 | |
Nektar Therapeutics (NKTR) | 0.3 | $312k | 9.5k | 32.84 | |
Voyager Therapeutics (VYGR) | 0.3 | $310k | 33k | 9.39 | |
Dova Pharmaceuticals | 0.3 | $303k | 40k | 7.58 | |
Myriad Genetics (MYGN) | 0.3 | $291k | 10k | 29.10 | |
G1 Therapeutics (GTHX) | 0.3 | $287k | 15k | 19.13 | |
Odonate Therapeutics Ord | 0.3 | $282k | 20k | 14.10 | |
EQT Corporation (EQT) | 0.2 | $213k | 11k | 18.85 | |
AMAG Pharmaceuticals | 0.1 | $152k | 10k | 15.20 | |
Lexicon Pharmaceuticals (LXRX) | 0.1 | $133k | 20k | 6.65 | |
Livent Corp | 0.1 | $138k | 10k | 13.80 | |
Oncomed Pharmaceuticals | 0.1 | $129k | 173k | 0.75 | |
Sito Mobile (STTO) | 0.1 | $126k | 140k | 0.90 | |
ImmunoGen | 0.1 | $106k | 22k | 4.82 | |
Yield10 Bioscience | 0.1 | $97k | 122k | 0.79 | |
Aevi Genomic | 0.1 | $90k | 128k | 0.70 | |
Tg Therapeutics (TGTX) | 0.1 | $62k | 15k | 4.13 | |
Cytokinetics (CYTK) | 0.1 | $63k | 10k | 6.30 | |
Workhorse Group Inc ordinary shares (WKHS) | 0.0 | $13k | 25k | 0.52 |